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Abstract  
Background: Cardio-vascular disease (CVD) is one of the main cause of mortality Worldwide and India is no 
exception. Unlike developed countries, where both CVD prevalence and mortality has been established to affect 
lower socio-economic status (SES), in India there is no consensus among researchers over socio-economic 
patterning of CVD prevalence but the mortality rate has been reported to disproportionately affect the 
economically weaker sections. Aims & Objectives: This article, focuses at the issue of how lack of good 
healthcare facilities and non-supportive health policies are affecting CVD mortality positively among lower SES of 
India. Challenges of the Indian healthcare system in context of lower SES can be described in terms of the issue of 
availability, accessibility and affordability. Inadequate policy and public healthcare system either leads to the 
problem of high Out-of-Pocket Payments (OPP) or opting out of the treatment, which further increases poverty 
and mortality among them. Moreover, limited insurance coverage and inadequate regulatory policies for alcohol 
and tobacco-leading CVD risk factors among lower SES groups – do little to discourage its use among them. 
Conclusion: Since, lower SES people in India are already under the burden of communicable diseases, 
government should take immediate steps to control the mortality among them by creating a supportive 
environment through pro-poor health policies and healthcare facilities. 
Keywords 
India; socio-economic status; health policies; CVD mortality; healthcare and treatment facilities. 
Introduction 
Cardiovascular diseases are responsible for causing 
highest number of deaths worldwide in the category 
of Non-Communicable Diseases (NCDs). In 2012 
alone, around 17.5 million people died worldwide 
from this disease and 80% of these deaths occurred 
only in developing countries (1). India also bears the 
burden of cardiovascular disease (CVD) in the form 
of 24% deaths annually (2). Once considered as a 
disease of affluent class only, CVD is now commonly 
prevalent among weaker sections of developed 
countries (3). Unlike developed countries where 
reversal of social gradient has been documented in 
the context of CVD, in India, there is no consensus 
over this relationship among scholar. Some studies 
have reported a positive association between CVD 
and socio-economic status (SES) (4,5,6,7,8,9) while 
others have reported a negative association 
(10,11,12,13,14). In a systematic review of CVD and 
its risk factors on Indian population, it has been 
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reported that in India, majority of modifiable 
cardiovascular risk factors (CVRFs) are associated 
with higher SES, and proportion of deaths among 
them is also higher but the rate of mortality is higher 
among lower SES (15). However, the cause of this 
higher mortality rate among lower SES has not been 
discussed. In a landmark study, same trend of CVD 
mortality rate has been reported and the cause of 
this difference in CVD mortality trend has been 
attributed to differences in availability of treatment 
facilities to the patients of higher and lower SES (14). 
This study concluded that if equal treatment facilities 
were provided to both SES, the disparity in mortality 
rate will disappear. Thus, the importance of 
treatment facility in determining CVD mortality 
among various SES of India has been suggested (14). 
Prevalence of a disease and its mortality rate 
depends on a number of factors and one of them is 
the availability of treatment facilities. Availability of 
treatment facilities in turn depends on health policy 
of that country. Even though India is now a world 
capital of diabetes (a CVD risk factor) (16) and a 
quarter of deaths in India are attributable to CVD 
only (2), Indian health policies still have acute 
diseases as priority and not chronic diseases (17). 
Aims & Objectives 
1. To discuss and explore the role of healthcare 
facilities in influencing CVD mortality and 
prevalence among lower SES in India. 
2. To look at how health policies that are 
influencing it for lower SES. 
 
Healthcare System for CVD and Socio-economic 
Status 
In the context of chronic diseases, Indian health care 
system can be characterized by “Heterogeneity”; 
where on one hand some people have all the access 
to treatment and care and on the other hand some 
people have difficulty in getting even basic 
treatment facilities (18). International Heart 
Protection Summit, (2011), has described the 
problems related to Indian healthcare system in 
three terms: lower availability, lower accessibility 
and lower affordability (19). Lower availability refers 
to the problem of absence of efficient and quality 
healthcare facilities in the form of specialist 
healthcare centres, sufficient number of doctors and 
nurses and cheaper evidence-based medicines for 
cardiac patients. It is notable that in India, only 150 
cardiologists are trained every year, which is clearly 
not sufficient for India’s huge population (20). 
Moreover, the ratio of availability of general doctors 
to the number of people is 1:1700, which is against 
WHO recommended ratio of 1:1000. 
 
Lower accessibility of Indian healthcare system 
refers to the unequal distribution of healthcare 
facilities. Majority of hospitals are located in urban 
India only, leading to problem of accessibility for 
rural and suburban population. Only 30% population 
of India lives in urban areas but they have the facility 
of 60% of hospitals (19). Lastly, the issue of lower 
affordability refers to the capability of common 
people to have quality care at affordable price. The 
treatment for any chronic disease is generally very 
expensive and CVD is no exception. Its treatment 
requires longer time period, costly drugs and 
sometimes hospitalization too, resulting into the 
problem of affordability for lower SES strata. The 
affordability to treatment facility is also affected by 
insurance facility available to patients but, in India, 
“The issue of affordability is further magnified by the 
low penetration of health insurance in India” (19). 
 
A prospective registry study in 50 cities and 89 
centres across India for acute coronary syndromes 
undertook 20,937 patients who were categorized 
into four socio-economic group viz. rich, upper-
middle, lower middle and poor class (14). It was 
found that the mortality rate due to acute coronary 
syndromes is higher among poor patients (8.2%) 
than rich patients (5.5%). They have attributed the 
reason for differential mortality to differences at the 
level of treatment. As rich patients can afford more 
costly drugs and interventional procedure than their 
counterparts, mortality rate among them is lower. It 
was found that the use of key treatments (both drug 
and coronary vascularization) differed significantly 
according to socio-economic status. Except 
antiplatelet drugs there was a socio-economic 
gradient in the intake of drugs (thrombolysis, beta 
blockers, lipid-lowering drugs, ACE inhibitor and 
anticoagulants drugs). Similarly, there was a 
significant difference for revascularization between 
patients of different SES. In comparison to 15.3% and 
7.5% of rich patients who received percutaneous 
coronary intervention (angioplasty) and coronary 
artery bypass graft surgery respectively, only 2.0% 
and 0.7% poor patients received the same. Another 
interesting finding reported in the same study is the 
mode of transportation for reaching hospital. They 
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reported that many poor patients die before 
reaching hospital due to the lack of proper 
ambulance services as well as due to the greater 
distance of hospitals, suggesting the actual mortality 
rate of poor patients might be higher than the 
reported one in their study. However, they have 
suggested that if both strata receive similar 
treatment facilities and reaches hospital on time, 
then mortality would be reduced and especially for 
lower socio-economic strata. 
 
CVD Healthcare Facilities and Out-of-Pocket 
Payment 
Poor section of India is still dependent on 
government hospitals for their treatment of CVD (6). 
As government healthcare sector is not in a good 
state, those who opt it have to wait long to see 
doctors and sometimes doctors are also not present. 
Even to avail basic facilities such as diagnostics or 
free medicines one needs to invest considerable 
amount of time. Some public hospitals do not have 
these basic facilities and issue of quality is also 
associated with government hospitals. Due to these 
limitations of public healthcare sector, people now 
have started opting for the private sector more. In a 
study done by IMS Institute for Healthcare 
Informatics in twelve states found that now people 
choose private healthcare over public system 
because of above mentioned causes (21). Similar 
findings were reported in a survey in Shimla, India 
and its adjacent area. People were found to use 
public services more for consultation but for 
diagnostic tests and drugs they are more depended 
on private sector (22). But choosing private 
healthcare can increase Out-of-Pocket-Payments 
(OPP) for patients and their families, especially for 
poor families. Chronic diseases such as CVD and its 
associated risk factors such as diabetes or 
hypertension have been found to cause high OPP, 
sometimes it even leads to borrowing of money, 
reduction in essential goods and/or services and in 
worst cases it leads to opting out of treatment (6). 
According to the reports of Government of India, in 
2004-05 alone, approximately 72% expenditure in 
healthcare was OPP (Figure 1) (23). It has been 
reported in a study that in India lowest income group 
bears the highest burden of healthcare expenditure 
on chronic disease (24). Low income group have to 
spend 70% of their average monthly income on 
treatment in case of a chronic disease while for high 
income group it is 45%. In the same study, it has also 
been reported that around 28% rural population opt 
out of treatment for chronic disease due to financial 
constraints. In worst situation, this OPP expenditure 
causes catastrophic expenditure which pushes 
already financially weak strata into poverty. Around 
39 million Indians are pushed to poverty due to this 
catastrophic expenditure (25). In a study role of OPP 
was analyzed w.r.t. caste and it has been reported 
that OPP is responsible for increasing the percentage 
of Below Poverty Line (BPL) among scheduled caste 
and scheduled tribe patients more than others (24). 
Moreover, it has also been found that due to high 
percentage of OPP for CVD treatment, poor people 
who already have limited financial resources are 
forced to reduce expenditure on food and education, 
which affects negatively their health as intake of 
nutritious food is important in CVD (26). 
 
Healthcare Policies for CVD  
India still has no national registry or data for 
recording the number of CVD cases and its related 
deaths. India’s CVD surveillance data collection is 
limited to only some states (27). There are many 
states for which there is no data including all north-
eastern states of India. Majority of surveys and 
surveillance data cannot be generalized to whole of 
India as they generally cover small number of sites. 
As rightly put that, ‘Many of these (studies) are 
repeated surveys in the same population at random 
time intervals’ (28). 
 
In 2009, Government of India launched its first 
program on chronic diseases including CVD, named, 
National Programme for Prevention and Control of 
Diabetes, Cardiovascular Diseases and Stroke 
(NPDCS). This is a welcoming move, even though a 
little late. Objectives of NPDCS include prevalence 
assessment of CVD and its risk factors, developing 
intervention modules and to establish a weekly 
CVD/stroke specialty clinic in each district. A pilot 
program has been started in ten districts of ten 
states with a budget allocation of Rs. 4,9160,000 per 
state (28). However, predicting anything about 
NPDCS will be quite early. 
 
Since, a high percentage of treatment expenditure is 
borne by patients themselves leading to high OPP, 
government health insurance scheme can play an 
important role for poor strata. A health insurance 
scheme named Rashtriya Swasthya Bima Yojana 
(RSBY) was launched by government in 2007 for BPL 
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(Below Poverty Line) people (29). Insurance 
coverage under this scheme is INR 30,000 for a family 
of 5 members. Though this program has been chosen 
as one of the top 18 successful and effective 
programs for social security by United Nations 
Development Programme (UNDP) and International 
Labour Organization (ILO), this scheme is under 
scrutiny by many people and agencies and it has 
been reported to be misused by many and has 
increased the level of fraud (30). Moreover, higher 
percentage of OPP made by poor people shows its 
inadequacy. 
 
Loopholes and drawbacks in Governments’ policies 
are evident from the fact that India is not just far 
behind developed countries but also from 
developing countries like China, Brazil and Thailand 
in the context of important health indicators (31). 
Government unwillingness to spend more on 
healthcare is also apparent from the fact that even 
after nearly 70 years of Independence, percentage 
GDP share of health sector is just 1.4 against global 
median of 5.0. Even in the draft of 12th Five Year Plan 
(2012-2017), health sector is still neglected by 
Government. With many drawbacks, it does not talk 
about any action to control OPP and there is a 
leaning towards private healthcare instead of 
strengthening Government healthcare system (32). 
 
Policies for Alcohol and Tobacco (CVD risk factors) 
In a recent systematic review, it has been reported 
that out of seven reviewed major modifiable risk 
factors of CVD, in India, lower SES was found to be 
higher on tobacco and less fibre diet only (15). This 
suggesting an important role of tobacco in higher 
CVD prevalence among lower SES. Other studies 
have also reported that prevalence of tobacco 
(33,34) and alcohol (35,36) is higher in poor and less 
educated population than rich and educated 
population. However, in India policies for alcohol and 
tobacco (CVD risk factors) are not in the favour of the 
health of the poor people. In contrast to developed 
countries, in India there is a high percentage of 
abstinence rate for alcohol among both genders, but 
the incidence and amount of alcohol consumption 
have been found to be higher among lower strata 
(37). Moreover, lower strata have been found to use 
desi/country liquor more because of its lower price 
and easy availability (38), which is sometimes 
adulterated with hazardous level of ethanol. But still 
there are no strict rules or policies for monitoring 
desi liquor in India leading to its higher consumption 
by poor people. It has been rightly noted by (35) that,  
The politics of alcohol in India is complex. 
Prohibition, a popular option for many women’s 
groups, is often used as a strategy by many political 
parties to campaign for elections. However, the 
associated loss of revenue and jobs, the increase in 
production and sale of illegal alcohol, and the crime 
and deaths due to methanol poisoning often lead to 
less stringent and more permissive sale of alcohol 
without enforcement of existing laws (related to the 
sale of alcohol, drunk driving and domestic violence). 
 
In a study, it has been suggested that in India 
smokeless tobacco is more used by poor and rural 
population both, followed by bidi while cigarette is 
more used by educated population. Bidi is also used 
by the poor sections of urban areas (34). However, 
from the governmental perspective, bidi industry is a 
small-scale industry and is thus supported by policy 
also (40). As smoking in public places is banned by 
the government of India, there is a shift in using the 
smokeless form of tobacco more, such as Khaini (34). 
As the percentage of Khaini addiction is higher in 
lower SES, policy makers need to take care of this 
aspect of tobacco also. Tobacco control policies in 
India lack rural orientation and as all strata of the 
rural population are equally affected by tobacco use 
(41), it has been proposed that government should 
also have rural orientation in tobacco control 
programs. 
 
Some researchers have proposed that those with low 
education are more prone to use alcohol and 
tobacco as they are generally not aware of the ill 
effects as compared to their counterparts thus 
increasing engagement in such activities (38,40). In 
India, where tobacco is used in various forms, there 
are many regional and religious variations for alcohol 
usage; thus, explanation in terms of only this 
proposition is not justifiable. Cultural factors which 
are sometimes regional and sometimes religious also 
play an important role. Such as, in Sikh community 
where tobacco usage is prohibited its prevalence 
rate is very low in comparison to other communities 
(34); similar is the case with alcohol consumption in 
Muslim community (42). Government needs to 
formulate policies keeping the above stated factors 
in perspective so that CVD mortality caused by these 
two preventable and modifiable risk factors can be 
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controlled with minimum burden on already 
financially crunched health sector. 
Conclusion 
Thus, we conclude that while tailoring CVD policies 
government should consider factors responsible for 
higher mortality rate among lower SES such as poor 
treatment facility, higher OPP and higher alcohol and 
tobacco addiction. Without considering these 
factors, it will be an impossible task to control CVD 
epidemic in near future in India. 
Recommendation 
Lower SES of India is prone to have high CVD 
mortality rate due to non-supportive policies and 
poor and unaffordable treatment facilities. Lower 
SES depends on public healthcare facilities for CVD 
treatment but due to non-availability and non-
accessibility of public health facilities, they tend to go 
for private treatments. As private treatments are 
costly and issue of affordability exists for weaker 
sections, it leads to either high OPP, which further 
increases poverty among them or opting out of the 
treatment, leading to increase in the mortality rate 
(Figure 2). In order to control CVD epidemic an 
implementation of appropriately designed policies 
are required which can help weaker strata to have 
better CVD treatment. 
 
Some pertinent measures for the same are: (i) 
increasing the number of trained cardiologists, (ii) 
providing cheaper medication facilities for poor 
patients, (iii) providing better ambulance services for 
such patients, (iv) providing better health insurance 
coverage and (v) having strict alcohol and tobacco 
control policies by taking into account economic, 
rural and regional variations. Also, there is a need to 
develop awareness programs and campaigns for 
various risk factors of CVD. Similar to HIV/AIDS and 
Tuberculosis awareness programs in which media 
(print and electronic) played an important role, 
government should formulate and launch awareness 
programs for CVD and its related risk factors also. 
There should be separate awareness programs for 
less educated and poor people. Every major district 
of India has a public Tuberculosis health centre and 
an ART centre but same is not true for public 
hospitals for cardiology; thus, restricting the 
availability of CVD treatment to poor people. 
Moreover, Rashtriya Swasthya Bima Yojana (RSBY) 
should have special provisions for CVD. 
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Figures 
FIGURE 1 SOURCE OF FUNDS FOR HEALTHCARE IN INDIA, 2004-05 (SOURCE: NATIONAL HEALTH 
ACCOUNTS, GOVERNMENT OF INDIA, 2009) 
 
FIGURE 2 VICIOUS CIRCLE OF POVERTY AND TREATMENT OF CVD. FIGURE SHOWING HOW 
ALREADY POOR SECTION OF INDIA ARE PUSHED TOWARDS FURTHER POVERTY DUE TO POOR 
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